Description

AOD-9604 Biovantage Labs Research Peptide

AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH176-191), studied for its role in lipolysis regulation and adipocyte metabolism research. Biovantage Labs supplies AOD-9604 at 99+% purity, verified by batch-specific HPLC and Mass Spectrometry. Domestically fulfilled from Canada. Not for human consumption. Biovantage Labs provides this compound at 99+% purity, confirmed by batch-specific HPLC and Mass Spectrometry analysis, as a lyophilized compound for use in controlled laboratory settings.

Molecular Profile and Chemical Specifications

Specification	Detail
Molecular Formula	C78H123N23O23S2
Molecular Weight	1,815.1 Da
Sequence	Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (disulfide bridge C7-C15)
Purity	≥99+% (HPLC/MS verified)
Physical Form	Lyophilized white powder
CAS Number	221231-10-3

 

Primary Research Mechanisms

Beta-3 Adrenergic Receptor Activation and Lipolysis

AOD-9604 is studied for its activation of beta-3 adrenergic receptors in adipose tissue models, stimulating the enzymatic breakdown of stored lipids (lipolysis) without the insulinogenic effects associated with full-length growth hormone.

AOD-9604 is derived from the C-terminal region of HGH (Human Growth Hormone) and is studied specifically because it reproduces certain lipolytic properties of the parent molecule without engaging the full GH receptor signalling cascade, a distinction that makes comparative AOD-9604/HGH research designs particularly informative.

Lipogenesis Inhibition

Complementary to its lipolytic activity, AOD-9604 has been examined in adipocyte research models for its capacity to inhibit lipogenesis the conversion of non-lipid substrates into stored fat through mechanisms independent of growth hormone receptor activation.

Cartilage and Bone Research Applications

Beyond metabolic research, AOD-9604 has been investigated in osteoarthritis and cartilage repair models. Studies have examined its interaction with TGF-beta signalling in chondrocyte cultures as a separate line of investigation from its metabolic properties.

For metabolic research protocols examining multiple pathways simultaneously, Semaglutide, a GLP-1 receptor agonist, is studied as a mechanistically distinct compound targeting incretin signalling rather than the adrenergic lipolytic axis examined in AOD-9604 research.

Reconstitution Protocol

• Reconstitute using sterile bacteriostatic water or 0.9% sodium chloride solution
• Introduce diluent slowly along the interior vial wall do not inject directly onto the lyophilized cake
• Swirl gently until fully dissolved do not shake or vortex
• Allow the vial to equilibrate to room temperature before opening to prevent condensation

Storage and Stability

Storage Condition	State	Estimated Stability
-20°C to -80°C	Lyophilized	24+ months
2°C to 8°C	Lyophilized	12 months
Room temperature (20°C)	Lyophilized	3 months
2°C to 8°C	Reconstituted	7 to 14 days

 

Store in a desiccated environment away from UV exposure. Avoid repeated freeze-thaw cycles, which degrade peptide chain integrity over time.

AOD-9604 Research FAQ

Q: Does AOD-9604 interact with the insulin or IGF-1 axis?

A: Research indicates AOD-9604 does not significantly stimulate insulin secretion or interact with the IGF-1 axis at research concentrations a property that distinguishes it from full-length growth hormone in metabolic study designs.

Q: Is AOD-9604 for human use?

A: No. AOD-9604 supplied by Biovantage Labs is strictly for laboratory research purposes. It is not approved for human consumption, veterinary use, or clinical application.

Q: What purity standard does Biovantage Labs apply?

A: Every batch is verified at 99+% purity using HPLC to confirm compound concentration and Mass Spectrometry to confirm molecular identity. Batch-specific COA documentation is available upon request.

Q: Where does Biovantage Labs ship from?

A: All Biovantage Labs products are fulfilled domestically from within Canada, eliminating customs clearance risk and reducing transit time compared to international suppliers.